HuGE Literature Finder
Records 1-30
|
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
BMC cancer 2019 Aug 19 (1): 772. Casula Milena, Paliogiannis Panagiotis, Ayala Fabrizio, De Giorgi Vincenzo, Stanganelli Ignazio, Mandalà Mario, Colombino Maria, Manca Antonella, Sini Maria Cristina, Caracò Corrado, Ascierto Paolo Antonio, Satta Rosanna Rita, , Lissia Amelia, Cossu Antonio, Palmieri Giuseppe, |
|
Non-Invasive Buccal Swab Gene Testing for Skin Cancer Risk
Journal of drugs in dermatology : JDD 2019 May 18 (5): 448-453. Moy Lauren, Lyons Alexis B., Fox William, Glicksman Marcie A., Moy Ronald, Tung Rebec |
|
Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours.
Veterinary journal (London, England : 1997) 2019 May 247 71-74. Vozdova Miluse, Kubickova Svatava, Fictum Petr, Fröhlich Jan, Jelinek Frantisek, Rubes Ji |
|
Predictive genetic profiles for regional lymph node metastasis in primary cutaneous melanoma: a case-matched pilot study.
Melanoma research 2018 Sep . Nye Anthony, Collins Justin D, Porter Caroline L, Montes de Oca Mary, George Kathryn, Stafford Colin G, Schammel Christine M G, Horton Samuel, Trocha Steven |
|
Skin involvement by chronic lymphocytic leukemia is frequently associated with unrelated neoplastic or inflammatory cutaneous disease and is not indicative of general disease progression.
The British journal of dermatology 2018 Sep . Thiesen I, Wehkamp U, Brüggemann M, Ritgen M, Murga Penas E M, Klapper W, Oschlies |
|
Female genitourinary tract melanoma: mutation analysis with clinicopathologic correlation: a single-institution experience.
Melanoma research 2018 Jul . Saglam Ozlen, Naqvi Syeda M H, Zhang Yonghong, Mesa Tania, Teer Jamie K, Yoder Sean, Lee Jae, Messina Ja |
|
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
European journal of cancer (Oxford, England : 1990) 2018 May 97 7-15. Cavalieri S, Perrone F, Miceli R, Ascierto P A, Locati L D, Bergamini C, Granata R, Alfieri S, Resteghini C, Galbiati D, Busico A, Paielli N, Patuzzo R, Maurichi A, Gallino G, Ruggeri R, Mariani L, Palla M, Licitra L, Bossi |
|
Mutation profiling of key cancer genes in primary breast cancers and their distant metastases.
Cancer research 2018 Apr . Schrijver Willemijne Ame, Selenica Pier, Lee Ju Youn, Ng Charlotte K Y, Burke Kathleen, Piscuoglio Salvatore, Berman Samuel H, Reis-Filho Jorge S, Weigelt Britta, Van Diest Paul J, Moelans Cathy |
|
Poly ADP-ribose polymerase-1 as a potential therapeutic target in Merkel cell carcinoma.
Head & neck 2018 Mar . Ferrarotto Renata, Cardnell Robert, Su Shirley, Diao Lixia, Eterovic A Karina, Prieto Victor, Morrisson William H, Wang Jing, Kies Merrill S, Glisson Bonnie S, Byers Lauren Averett, Bell Dia |
|
Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma.
Genes, chromosomes & cancer 2018 Jan . Benfodda Meriem, Gazal Steven, Descamps Vincent, Basset-Seguin Nicole, Deschamps Lydia, Thomas Luc, Saiag Philippe, Zanetti Roberto, Sacchetto Lidia, Chiorino Giovanna, Scatolini Maria, Grandchamp Bernard, Soufir Nad |
|
TP53 Gene Polymorphisms and Occupational Skin Cancer Risks for Workers of Glass Fiber Manufacture.
Iranian journal of public health 2017 Nov 46 (11): 1495-1501. Mukhammadiyeva Guzel F, Karimov Denis O, Bakirov Akhat B, Karimova Liliya |
|
Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Oct . Zilberg Catherine, Lee Matthew Weicai, Yu Bing, Ashford Bruce, Kraitsek Spiridoula, Ranson Marie, Shannon Kerwin, Cowley Mark, Iyer N Gopalakrishna, Palme Carsten E, Ch'ng Sydney, Low Tsu-Hui Hubert, O'Toole Sandra, Clark Jonathan R, Gupta Ru |
|
A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours.
European journal of cancer (Oxford, England : 1990) 2017 Mar 76 144-151. de Jonge Maja, de Weger Vincent A, Dickson Mark A, Langenberg Marlies, Le Cesne Axel, Wagner Andrew J, Hsu Karl, Zheng Wei, Macé Sandrine, Tuffal Gilles, Thomas Koruth, Schellens Jan H |
|
Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.
Medical oncology (Northwood, London, England) 2017 Feb 34 (2): 19. Oliveira Cristiane, Lourenço Gustavo Jacob, Rinck-Junior José Augusto, de Moraes Aparecida Machado, Lima Carmen Silvia Pass |
|
Clinicopathological features and clinical outcomes associated with TP53 and BRAF(N)(on-)(V)(600) mutations in cutaneous melanoma patients.
Cancer 2016 Dec . Kim Dae Won, Haydu Lauren E, Joon Aron Y, Bassett Roland L, Siroy Alan E, Tetzlaff Michael T, Routbort Mark J, Amaria Rodabe N, Wargo Jennifer A, McQuade Jennifer L, Kemnade Jan, Hwu Patrick, Woodman Scott E, Roszik Jason, Kim Kevin B, Gershenwald Jeffrey E, Lazar Alexander J, Davies Michael |
|
Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome.
Journal of the American Academy of Dermatology 2016 Sep 75 (3): 595-602. Lawrence Nicholas F, Hammond Marc R, Frederick Dennie T, Su Yuhua, Dias-Santagata Dora, Deng April, Selim M Angelica, Mahalingam Meera, Flaherty Keith T, Hoang Mai |
|
Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
Oncotarget 2016 Sep 7 (38): 61575-61586. van Ginkel Joost H, de Leng Wendy W J, de Bree Remco, van Es Robert J J, Willems Stefan |
|
Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.
Neurobiology of aging 2016 Jul . Lubbe S J, Escott-Price V, Brice A, Gasser T, Pittman A M, Bras J, Hardy J, Heutink P, Wood N M, Singleton A B, Grosset D G, Carroll C B, Law M H, Demenais F, Iles M M, , Bishop D T, Newton-Bishop J, Williams N M, Morris H R, |
|
Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma.
The Journal of pathology 2016 Jun . Tetzlaff Michael T, Singh Rajesh R, Seviour Elena G, Curry Jonathan L, Hudgens Courtney W, Bell Diana, Wimmer Daniel A, Ning Jing, Czerniak Bogdan A, Zhang Li, Davies Michael A, Prieto Victor G, Broaddus Russell R, Ram Prahlad, Luthra Rajyalakshmi, Esmaeli Bi |
|
Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
Cancer research 2016 Jan . Vineretsky Karin A, Karagas Margaret R, Christensen Brock C, Kuriger-Laber Jacquelyn K, Perry Ann E, Storm Craig A, Nelson Heather |
|
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.
Cancer research 2015 Dec . Wong Stephen Q, Waldeck Kelly, Vergara Ismael A, Schröder Jan, Madore Jason, Wilmott James S, Colebatch Andrew J, De Paoli-Iseppi Ricardo, Li Jason, Lupat Richard, Semple Timothy, Arnau Gisela Mir, Fellowes Andrew, Leonard J Helen, Hruby George, Mann Graham J, Thompson John F, Cullinane Carleen, Johnston Meredith, Shackleton Mark, Sandhu Shahneen, Bowtell David D L, Johnstone Ricky W, Fox Stephen B, McArthur Grant A, Papenfuss Anthony T, Scolyer Richard A, Gill Anthony J, Hicks Rodney J, Tothill Richard |
|
Correlation of Merkel cell polyomavirus positivity with PDGFR? mutations and survivin expression in Merkel cell carcinoma.
Journal of dermatological science 2015 Jul 79 (1): 43-9. Batinica M, Akgül B, Silling S, Mauch C, Zigrino |
|
Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 Jul 28 (7): 895-903. Jahn Stephan W, Kashofer Karl, Halbwedl Iris, Winter Gerlinde, El-Shabrawi-Caelen Laila, Mentzel Thomas, Hoefler Gerald, Liegl-Atzwanger Bernadet |
|
Genomic analysis of metastatic cutaneous squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Mar 21 (6): 1447-56. Li Yvonne Y, Hanna Glenn J, Laga Alvaro C, Haddad Robert I, Lorch Jochen H, Hammerman Peter |
|
Mutational landscape of aggressive cutaneous squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Dec 20 (24): 6582-92. Pickering Curtis R, Zhou Jane H, Lee J Jack, Drummond Jennifer A, Peng S Andrew, Saade Rami E, Tsai Kenneth Y, Curry Jonathan L, Tetzlaff Michael T, Lai Stephen Y, Yu Jun, Muzny Donna M, Doddapaneni Harshavardhan, Shinbrot Eve, Covington Kyle R, Zhang Jianhua, Seth Sahil, Caulin Carlos, Clayman Gary L, El-Naggar Adel K, Gibbs Richard A, Weber Randal S, Myers Jeffrey N, Wheeler David A, Frederick Mitchell |
|
Frequency and features of TP53 mutation in 30 Chinese patients with sporadic basal cell carcinoma.
Clinical and experimental dermatology 2014 Oct 39 (7): 829-34. Wang Y M, Huang Y S, Ma Z H, Bu D F, Wang Y, Tu P, Li |
|
A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.
Molecular cancer therapeutics 2014 Jul 13 (7): 1918-28. Xia Junfeng, Jia Peilin, Hutchinson Katherine E, Dahlman Kimberly B, Johnson Douglas, Sosman Jeffrey, Pao William, Zhao Zhongmi |
|
MDM2 SNP309 promoter polymorphism confers risk for hereditary melanoma.
Melanoma research 2014 Jun 24 (3): 190-7. Thunell Lena K, Bivik Cecilia, Wäster Petra, Fredrikson Mats, Stjernström Annika, Synnerstad Ingrid, Rosdahl Inger, Enerbäck Charlot |
|
Association between genetic polymorphisms in apoptosis-related genes and risk of cutaneous melanoma in women and men.
Journal of dermatological science 2014 May 74 (2): 135-41. Oliveira Cristiane, Lourenço Gustavo Jacob, Rinck-Junior José Augusto, Cintra Maria Letícia, Moraes Aparecida Machado, Lima Carmen Silvia Pass |
|
Genetic association between p53 codon 72 polymorphism and risk of cutaneous squamous cell carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Apr 35 (4): 3899-903. Liu Ting, Lei Zeyuan, Pan ZhengYing, Chen Yu, Li Xiang, Mao TongChun, He Qian, Fan Dong |
|
Clonal architectures and driver mutations in metastatic melanomas.
PloS one 2014 9 (11): e111153. Ding Li, Kim Minjung, Kanchi Krishna L, Dees Nathan D, Lu Charles, Griffith Malachi, Fenstermacher David, Sung Hyeran, Miller Christopher A, Goetz Brian, Wendl Michael C, Griffith Obi, Cornelius Lynn A, Linette Gerald P, McMichael Joshua F, Sondak Vernon K, Fields Ryan C, Ley Timothy J, Mulé James J, Wilson Richard K, Weber Jeffrey |
|
Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma.
Journal of cancer research and clinical oncology 2013 Jul 139 (7): 1199-206. Oliveira Cristiane, Rinck-Junior José Augusto, Lourenço Gustavo Jacob, Moraes Aparecida Machado, Lima Carmen Silvia Pass |
|
Polymorphisms in the p27kip-1 and prohibitin genes denote novel genes associated with melanoma risk in Brazil, a high ultraviolet index region.
Melanoma research 2013 Jun 23 (3): 231-6. Francisco Guilherme, Gonçalves Fernanda T, Luiz Olinda C, Saito Renata F, Toledo Rodrigo A, Sekiya Tomoko, Tortelli Tharcísio C, Violla Esther D V B, Furuya Mazzotti Tatiane K, Cirilo Priscila D R, Festa-Neto Cyro, Sanches José A, Gattás Gilka J F, Eluf-Neto José, Chammas Rog |
|
Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.
PloS one 2013 8 (11): e79983. Ye Jun, Li Xiao-Fen, Wang Yong-Dong, Yuan Yi |
|
Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Aug 33 (4): 927-33. Pandith Arshad A, Khan Nighat P, Rashid Nargis, Azad Niyaz, Zaroo Inam, Hafiz Adil, Siddiqi Mushtaq |
|
Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanoma.
The Journal of investigative dermatology 2012 May 132 (5): 1471-8. Cotignola Javier, Chou Joanne F, Roy Pampa, Mitra Nandita, Busam Klaus, Halpern Allan C, Orlow Ire |
|
p53 codon 72 polymorphisms and random amplified polymorphic DNA analysis of non-melanoma skin cancer through archival formalin-fixed paraffin-embedded tissue.
Oncology reports 2012 Mar 27 (3): 753-63. Yoke-Kqueen Cheah, Ab Mutalib Nurul-Syakima, Sidik Shiran Mohd, Learn-Han Lee, Geok-Chin T |
|
RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Jan 30 (3): 316-21. Oberholzer Patrick A, Kee Damien, Dziunycz Piotr, Sucker Antje, Kamsukom Nyam, Jones Robert, Roden Christine, Chalk Clinton J, Ardlie Kristin, Palescandolo Emanuele, Piris Adriano, MacConaill Laura E, Robert Caroline, Hofbauer Günther F L, McArthur Grant A, Schadendorf Dirk, Garraway Levi |
|
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.
The New England journal of medicine 2012 Jan 366 (3): 207-15. Su Fei, Viros Amaya, Milagre Carla, Trunzer Kerstin, Bollag Gideon, Spleiss Olivia, Reis-Filho Jorge S, Kong Xiangju, Koya Richard C, Flaherty Keith T, Chapman Paul B, Kim Min Jung, Hayward Robert, Martin Matthew, Yang Hong, Wang Qiongqing, Hilton Holly, Hang Julie S, Noe Johannes, Lambros Maryou, Geyer Felipe, Dhomen Nathalie, Niculescu-Duvaz Ion, Zambon Alfonso, Niculescu-Duvaz Dan, Preece Natasha, Robert Lídia, Otte Nicholas J, Mok Stephen, Kee Damien, Ma Yan, Zhang Chao, Habets Gaston, Burton Elizabeth A, Wong Bernice, Nguyen Hoa, Kockx Mark, Andries Luc, Lestini Brian, Nolop Keith B, Lee Richard J, Joe Andrew K, Troy James L, Gonzalez Rene, Hutson Thomas E, Puzanov Igor, Chmielowski Bartosz, Springer Caroline J, McArthur Grant A, Sosman Jeffrey A, Lo Roger S, Ribas Antoni, Marais Richa |
|
Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.
PloS one 2012 7 (4): e34422. Loeb Keith R, Asgari Maryam M, Hawes Stephen E, Feng Qinghua, Stern Joshua E, Jiang Mingjun, Argenyi Zsolt B, de Villiers Ethel-Michele, Kiviat Nancy |
|
POMC and TP53 genetic variability and risk of basal cell carcinoma of skin: Interaction between host and genetic factors.
Journal of dermatological science 2011 Jul 63 (1): 47-54. Rizzato Cosmeri, Scherer Dominique, Rudnai Peter, Gurzau Eugen, Koppova Kvetoslava, Hemminki Kari, Canzian Federico, Kumar Rajiv, Campa Danie |
|
The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer.
Carcinogenesis 2011 Mar 32 (3): 327-30. Almquist Lindsay M, Karagas Margaret R, Christensen Brock C, Welsh Marleen M, Perry Ann E, Storm Craig A, Nelson Heather |
|
TP53 Arg72Pro polymorphism and skin cancer risk: a meta-analysis.
The Journal of investigative dermatology 2011 Jan 131 (1): 220-8. Jiang De-Ke, Wang Wen-Zhang, Ren Wei-Hua, Yao Lei, Peng Bo, Yu Lo |
|
Dermatologic findings in renal transplant recipients: Possible effects of immunosuppression regimen and p53 mutations.
Transplantation proceedings 2010 Sep 42 (7): 2538-41. Serdar Z A, Eren P A, Canbakan M, Turan K, Tellioglu G, Gülle S, Ozgezer T, Kara M, Berber I, Titiz M |
|
MDM2 SNP309 and p53 Arg72Pro in cutaneous melanoma: association between SNP309 GG genotype and tumor Breslow thickness.
Journal of human genetics 2010 Aug 55 (8): 518-24. Capasso Mario, Ayala Fabrizio, Avvisati Rosa Anna, Russo Roberta, Gambale Antonella, Mozzillo Nicola, Ascierto Paolo Antonio, Iolascon Achil |
|
Association of the DSS1 c.143G>A polymorphism with skin squamous cell carcinoma.
The Journal of investigative dermatology 2010 Jun 130 (6): 1719-25. Venza Mario, Catalano Teresa, Visalli Maria, Venza Isabella, Lentini Maria, Curia Maria Cristina, Mariani-Costantini Renato, Teti Dia |
|
The glutathione-S-transferase P1 polymorphisms correlates with changes in expression of TP53 tumor suppressor in cutaneous basal cell carcinoma.
Journal of dermatological science 2009 Dec 56 (3): 208-10. Gorji Hassan, Shahbazi Nassim, Habibollahi Peiman, Tavangar Seyed Mohammad, Firooz Alireza, Ghahremani Mohammad |
|
A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer.
The British journal of dermatology 2009 Nov 161 (5): 1067-71. Prior S L, Griffiths A P, Lewis P |
|
Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population.
Mutation research 2009 May 676 (1-2): 5-10. Hussain Ishraq, ul Rehman Shakeel, Afroze Dil, Zahoor Lubna, Abdullah Safiya, Hafiz Adil, Shah Zafar A, Iqbal Shabir, Shaffi Mohammad, Das B C, Siddiqi Mushtaq |
|
Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Apr 15 (7): 7. Firoz EF, Warycha M, Zakrzewski J, Pollens D, Wang G, Shapiro R, Berman R, Pavlick A, Manga P, Ostrer H, Celebi JT, Kamino H, Darvishian F, Rolnitzky L, Goldberg JD, Osman I, Polsky D |
|
A functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancer.
Cancer causes & control : CCC 2009 Mar 20 (2): 171-9. Nan Hongmei, Qureshi Abrar A, Hunter David J, Han Jia |
|
Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk.
The British journal of dermatology 2008 Aug 159 (2): 314-21. Nan H, Qureshi A A, Hunter D J, Han |
|
p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer.
Mutation research 2007 Jun 619 (1-2): 38-44. Bendesky Andres, Rosales Alejandra, Salazar Ana María, Sordo Monserrat, Peniche Jorge, Ostrosky-Wegman Patric |
|
p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
The British journal of dermatology 2007 Feb 156 (2): 357-62. Stefanaki I, Stratigos A J, Dimisianos G, Nikolaou V, Papadopoulos O, Polydorou D, Gogas H, Tsoutsos D, Panagiotou P, Kanavakis E, Antoniou C, Katsambas A |
|
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
Familial cancer 2007 6 (4): 453-61. Monnerat Christian, Chompret Agnès, Kannengiesser Caroline, Avril Marie-Françoise, Janin Nicolas, Spatz Alain, Guinebretière Jean-Marc, Marian Catalin, Barrois Michel, Boitier Françoise, Lenoir Gilbert M, Bressac-de Paillerets Brigit |
|
The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US Caucasian women.
Molecular carcinogenesis 2006 Sep 45 (9): 694-700. Han Jiali, Cox David G, Colditz Graham A, Hunter David |
|
p53 codon 72 polymorphism in basal cell carcinoma of the skin.
Pathology oncology research : POR 2006 12 (1): 29-33. Pezeshki Abdulmohammad, Sari-Aslani Fatemeh, Ghaderi Abbas, Doroudchi Mehrnoo |
|
Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2005 May 7 (4): 156-64. Soto Martínez José Luis, Cabrera Morales Carmen M, Serrano Ortega Sabio, López-Nevot Miguel Ang |
|
Association of p53 arginine polymorphism with skin cancer.
International journal of dermatology 2004 Jul 43 (7): 489-93. de Oliveira Walmar Roncalli P, Rady Peter L, Grady James, Hughes Thomas K, Neto Cyro F, Rivitti Evandro A, Tyring Stephen |
|
p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma.
The Journal of investigative dermatology 2003 Dec 121 (6): 1510-4. Shen Hongbing, Liu Zhensheng, Strom Sara S, Spitz Margaret R, Lee Jeffrey E, Gershenwald Jeffrey E, Ross Merrick I, Mansfield Paul F, Duvic Madeleine, Ananthaswamy Honnavara N, Wei Qing |
|
Genetic polymorphism in p53 codon 72 and skin cancer in southwestern Taiwan.
Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering 2003 Jan 38 (1): 201-11. Chen Yen-Ching, Xu Lilian, Guo Yu-Liang Leon, Su Huey-Jen Jenny, Hsueh Yu-Mei, Smith Thomas J, Ryan Louise M, Lee Meei-Shyuan, Chaor Sheau-Chiou, Lee Julia Yu-Yun, Christiani David |
|
Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer.
The Journal of investigative dermatology 2002 Jul 119 (1): 84-90. McGregor Jane M, Harwood Catherine A, Brooks Louise, Fisher Sheila A, Kelly Deirdre A, O'nions Jenny, Young Antony R, Surentheran Thiru, Breuer Judith, Millard Thomas P, Lewis Cathryn M, Leigh Irene M, Storey Alan, Crook Timot |
|
TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with human papillomavirus status.
The Journal of investigative dermatology 2002 Jun 118 (6): 1026-31. Cairey-Remonnay Sandrine, Humbey Olivier, Mougin Christiane, Algros Marie P, Mauny Frédéric, Kanitakis Jean, Euvrard Sylvie, Laurent René, Aubin Franço |
|
p53 codon 72 polymorphism and human papillomavirus associated skin cancer.
Journal of clinical pathology 2001 Jul 54 (7): 539-42. O'Connor D P, Kay E W, Leader M, Atkins G J, Murphy G M, Mabruk M |
|
Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening?
Molecular carcinogenesis 2001 Jan 30 (1): 56-61. Bastiaens M T, Struyk L, Tjong-A-Hung S P, Gruis N, ter Huurne J, Westendorp R G, Vermeer B J, Bavinck J N, ter Schegget |
|
[Analysis of associations of polymorphic loci of a tumor suppressor gene TP53 with malignant neoplasms in glass fiber manufacturing workers].
Gigiena i sanitariia 0 (4): 59-61. Mukhammadiyeva G F, Bakirov A B, Karimova L K, Valeyeva E |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 23, 2020
- Content source: